Autolus Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Autolus Therapeutics (Nasdaq: AUTL) will participate in two investor conferences in early June 2026. CEO Dr. Christian Itin will present at the William Blair 46th Annual Growth Stock Conference on June 2 and the Jefferies Global Healthcare Conference on June 3, with live webcasts and 90-day replays.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LONDON and GAITHERSBURG, Md., May 27, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the Company will present and host meetings at two upcoming investor conferences.

William Blair’s 46th Annual Growth Stock Conference
Date and time: June 2, 2026; 1:20pm CDT / 7:20pm BST
Location: Chicago, IL
Presenter: Chief Executive Officer Dr. Christian Itin

Jefferies Global Healthcare Conference
Date and time: June 3, 2026; 10:30am EDT / 3:30pm BST
Location: New York, NY
Presenter: Chief Executive Officer Dr. Christian Itin

Webcasts of the presentations will be available on the “Events” page in the “Investor Relations & Media” section of the Company’s website at https://www.autolus.com/investor-relations-media/events/. A replay of the webcasts will be archived on the Company’s website for 90 days following the presentations.

About Autolus Therapeutics plc
Autolus Therapeutics plc (Nasdaq: AUTL) is a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation T cell therapies and candidates for the treatment of cancer and autoimmune disease. Using a broad suite of proprietary and modular T cell programming technologies, Autolus is engineering precisely targeted and controlled T cell therapies that are designed to better recognize target cells, break down their defense mechanisms and eliminate these cells. Autolus has a marketed therapy, AUCATZYL^®, and a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. For more information, please visit www.autolus.com. 

Contact:

Amanda Cray 
+1 617-967-0207 
a.cray@autolus.com 

FAQ

When will Autolus Therapeutics (NASDAQ: AUTL) present at the William Blair 46th Annual Growth Stock Conference?

Autolus Therapeutics will present at the William Blair 46th Annual Growth Stock Conference on June 2, 2026, at 1:20pm CDT / 7:20pm BST. According to the company, the event will be held in Chicago, Illinois, with CEO Dr. Christian Itin presenting.

What are the details of Autolus Therapeutics (AUTL) presentation at the Jefferies Global Healthcare Conference 2026?

Autolus Therapeutics will present at the Jefferies Global Healthcare Conference on June 3, 2026, at 10:30am EDT / 3:30pm BST. According to the company, the conference will take place in New York, with CEO Dr. Christian Itin serving as presenter.

How can investors watch the Autolus Therapeutics (AUTL) webcasts for the June 2026 investor conferences?

Investors can watch the Autolus Therapeutics conference webcasts on the Events page in the Investor Relations & Media section of its website. According to the company, both William Blair and Jefferies presentations will be available via live webcast for remote viewing.

Will replays of the Autolus Therapeutics (NASDAQ: AUTL) June 2026 conference presentations be available?

Yes, replays of Autolus Therapeutics’ June 2026 conference presentations will be archived on its website for 90 days. According to the company, investors can access these replays through the Events section in the Investor Relations & Media area.

Who will represent Autolus Therapeutics (AUTL) at the June 2026 William Blair and Jefferies conferences?

Autolus Therapeutics will be represented by its Chief Executive Officer, Dr. Christian Itin, at both conferences. According to the company, Dr. Itin will deliver the presentations in Chicago on June 2 and New York on June 3, 2026.

What is the significance of Autolus Therapeutics (AUTL) joining the William Blair Growth Stock and Jefferies Healthcare conferences?

Autolus Therapeutics’ participation provides scheduled forums to update investors on its business at two major conferences. According to the company, CEO-led presentations on June 2 and June 3, 2026, will be accessible globally via webcast and archived replays.